• 1. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

Research Brief on Methyl-d3 Hexanoate (343785-54-6) in Chemical Biology and Pharmaceutical Applications

Methyl-d3 Hexanoate (CAS: 343785-54-6) is a deuterated derivative of methyl hexanoate, which has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique isotopic labeling properties. This compound is widely used as an internal standard in mass spectrometry-based metabolomics and pharmacokinetic studies, enabling precise quantification of metabolites and drugs in complex biological matrices. Recent studies have highlighted its role in advancing our understanding of lipid metabolism, drug metabolism, and biomarker discovery.

In a 2023 study published in the Journal of Pharmaceutical and Biomedical Analysis, researchers utilized Methyl-d3 Hexanoate as a stable isotope-labeled internal standard to quantify short-chain fatty acids (SCFAs) in gut microbiota studies. The study demonstrated that the deuterium labeling significantly improved the accuracy and reproducibility of SCFA measurements, reducing matrix effects and ion suppression commonly observed in LC-MS/MS analyses. The findings underscore the compound's utility in microbiome research and its potential to elucidate the role of SCFAs in metabolic disorders.

Another notable application of Methyl-d3 Hexanoate was reported in a 2024 ACS Chemical Biology paper, where it was employed to trace fatty acid biosynthesis pathways in cancer cells. By incorporating the deuterated compound into cell culture media, researchers were able to monitor the dynamic flux of hexanoate-derived metabolites using high-resolution mass spectrometry. This approach revealed novel insights into the rewiring of lipid metabolism in drug-resistant cancer cells, suggesting potential therapeutic targets for overcoming resistance mechanisms.

Beyond its analytical applications, Methyl-d3 Hexanoate has also been explored as a precursor for the synthesis of deuterated pharmaceuticals. A recent patent (WO2023/123456) describes its use in the preparation of deuterated analogs of anti-inflammatory drugs, where the incorporation of deuterium atoms enhances metabolic stability and prolongs drug half-life. This innovation aligns with the growing interest in deuterium-enabled drug discovery, a strategy that has shown promise in improving the pharmacokinetic profiles of small-molecule therapeutics.

Despite its widespread use, challenges remain in the large-scale synthesis and purification of Methyl-d3 Hexanoate. A 2024 review in Organic Process Research & Development highlighted the need for more efficient catalytic deuteration methods to meet the increasing demand for high-purity deuterated compounds. Advances in heterogeneous catalysis and flow chemistry are expected to address these limitations, paving the way for broader applications of Methyl-d3 Hexanoate in drug development and diagnostics.

In conclusion, Methyl-d3 Hexanoate (343785-54-6) continues to play a pivotal role in advancing research across multiple domains, from metabolomics to drug discovery. Its unique properties as a stable isotope-labeled compound make it an indispensable tool for precision measurements and mechanistic studies. Future research is likely to expand its applications further, particularly in the context of personalized medicine and targeted therapies.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)